ArticleScientific reports2025
Next-generation COVID-19 detection using a metasurface biosensor with machine learning-enhanced refractive index sensing.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Recent advances in MXene-molecularly imprinted polymer hybrid nanocomposites for electrochemical detection of pandemic-related biomarkers.Analytical and bioanalytical chemistry · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This work introduces a high-performance graphene-silver hybrid metasurface biosensor for the fast and precise detection of COVID-19. Through parametric optimization with COMSOL Multiphysics, the sensor achieves a sensitivity of 400 GHz/RIU, a figure of merit (FOM) of 5.000 RIU⁻¹, and a Q factor of 12.7 within the refractive index range of 1.334-1.355 RIU. A machine learning framework enhances predictive reliability across different refractive indices, as reflected by a coefficient of determination (R²) of 0.90. The fabrication strategy-combining CVD graphene growth, electron beam lithography, and silver deposition-ensures scalability and practical realization. The novelty of this study lies in the synergistic integration of a graphene-silver metasurface platform with machine learning-based predictive modeling, enabling rapid, label-free, and highly accurate COVID-19 detection. Unlike conventional RT-PCR and antigen-based tests, which suffer from delays, high costs, or reduced sensitivity in asymptomatic cases, the proposed sensor achieves superior balance between sensitivity, figure of merit, and predictive accuracy, thereby surpassing state-of-the-art optical and terahertz biosensors. This positions the device as a novel, portable, and cost-effective diagnostic tool for next-generation pandemic preparedness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.